Items where authors include "Regan, M."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Quick, V., Abusalameh, M., Ahmed, S. et al. (72 more authors) (2024) Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England. Rheumatology, 63 (12). pp. 3407-3414. ISSN 1462-0324

Zhao, S.S. orcid.org/0000-0002-3558-7353, Rogers, K., Kearsley-Fleet, L. orcid.org/0000-0003-0377-1575 et al. (195 more authors) (2024) Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritis. Rheumatology, 63 (3). pp. 648-656. ISSN 1462-0324

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Zhao, S.S. orcid.org/0000-0002-3558-7353, Rogers, K., Kearsley-Fleet, L. orcid.org/0000-0003-0377-1575 et al. (195 more authors) (2024) Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritis. Rheumatology, 63 (3). pp. 648-656. ISSN 1462-0324

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Bezzina, O.M., Gallagher, P., Mitchell, S. et al. (30 more authors) (2017) Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome - Capturing the discrepancy. Arthritis Care and Research, 69 (11). pp. 1714-1723. ISSN 2151-464X

Ng, W.F., Miller, A., Bowman, S.J. et al. (96 more authors) (2016) Physical activity but not sedentary activity is reduced in primary Sjögren’s syndrome. Rheumatology International. ISSN 0172-8172

Howard Tripp, N., Tarn, J., Natasari, A. et al. (29 more authors) (2016) Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines. RMD Open, 2 (2). e000282. ISSN 2056-5933

Monograph

Bambra, C., Munford, L., Heather, B. et al. (8 more authors) (2018) Health for Wealth: Building a Healthier Northern Powerhouse for UK Productivity. Report. Northern Health Sciences Alliance

Proceedings Paper

Brown, H., Munford, L., Wilding, A. et al. (8 more authors) (2019) Health for wealth : decomposing the role of health on productivity in England using individual and population-level longitudinal data from the UK. In: The Lancet. Public Health Science 2019: A National Conference Dedicated to New Research in UK Public Health, 29 Nov 2019, London, UK. Elsevier BV , S28.